Acute Ischemic Stroke
Conditions
Brief summary
Prospective registry of clinical and radiological data in acute ischemic stroke patients after endovascular treatment.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Age 18 years or older * Patients with ischemic stroke and cerebral arterial occlusion treated with endovascular revascularization. * All stroke severities and vascular distributions are eligible. * Informed written consent signed by the patient, verbal consent from the patient as witnessed by a non-participating health care person or consent by the signature of the patient's family must be provided before inclusion. Patients for whom no informed consent can be obtained will not be included in the study but will be treated according to standard guidelines.
Exclusion criteria
• Patient not eligible for the study or not available for follow-up assessments (e.g. non- resident).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Modified Rankin Scale Score | 3 months | Modified Rankin Scale Score (mRS), min 0, max 6 |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Infarct volume | 1 day | Infarct volume (ml) |
| National Institute of Health Stroke Scale Score | discharge | National Institute of Health Stroke Scale Score (NIHSS, min 0, max 42) |
| Death due to any cause | 3 months | Mortality |
| Volume of new areas of diffusion restriction | 1 day | Volume of new areas of diffusion restriction |
| serious adverse events | 3 months | serious adverse events |
| Incidence of symptomatic intracranial hemorrhage | 1 day | Incidence of symptomatic intracranial hemorrhage (SICH) |
Countries
Norway